U.S. Commences Probe into Questcor (QCOR) Over Marketing Practices
Tweet Send to a FriendGet Alerts QCOR Hot Sheet
Price: $35.29 -2%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.9%
EPS Growth %: +24.6%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.9%
EPS Growth %: +24.6%
Trade QCOR Now!
On September 21, 2012, Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) became aware of a U.S. government investigation involving the Company’s promotional practices.
The Company intends to cooperate with the government in its investigation. Company representatives will not be able to provide any additional information on this matter, other than through potential public Regulation FD-compliant disclosures.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The Company intends to cooperate with the government in its investigation. Company representatives will not be able to provide any additional information on this matter, other than through potential public Regulation FD-compliant disclosures.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Sprint (S), SoftBank Receive Final State Regulatory Approval in Proposed Deal
- NASDAQ OMX (NDAQ), Thomson Reuters (TRI) Enter Asset Purchase Agreement
- Major ResCap Creditor MBIA (MBI) Trades Higher on Ally Settlement
Create E-mail Alert Related Categories
Corporate News, Litigation
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
